Making top-quality cancer care accessible to all.100% free, no account required.

Boosting Comfort with Virtual Reality for Digestive Cancer Pain Relief

NCT04907643 · Recruiting
About this trial

This study looks at how virtual reality (VR) can help people with cancer in the digestive system who have pain. Many patients experience ongoing belly pain that can affect their daily life. The study will compare different types of VR experiences to see which helps reduce pain and improve quality of life. It aims to gather data from patients using VR technology over a 60-day period.

Locations and contact

This trial is running at 1 location in the United States. It is currently recruiting.

United States1 location · 1 recruiting
  • Cedars-Sinai Medical CenterLos Angeles, CaliforniaRecruiting
Who to ask about joining
Who can join

Adults aged 18 to 99 with a type of cancer in the digestive system and ongoing pain can participate. The study is open to both men and women. Some people cannot join if they have certain health conditions or brain tumors, or if they cannot understand the consent form. The trial team will confirm who is eligible to join.

What happens during the trial

Participants will be placed into one of three groups by chance. One group will use skills-based VR to learn coping techniques. Another group will use distraction-based VR to take their mind off the pain. The third group will use a non-immersive VR with basic videos. Everyone will use a VR headset and will be asked to use it daily for four weeks. They will also track their activity with a Fitbit and answer weekly questionnaires.

The trial team

The trial is led by Cedars-Sinai Medical Center, with help from the National Cancer Institute and the University of California, Los Angeles. The main doctors overseeing the study are Brennan Spiegel, MD, MSHS, and Scott Irwin, MD, PhD.

Important dates

The trial started on October 5, 2021, and is expected to finish by March 16, 2027. It is currently enrolling new participants.

Additional information

The trial's ID number is NCT04907643. It is not in a specific phase but is looking at how well the treatment works and its safety. The study plans to include 360 participants, and it is FDA-regulated for the device used.

Similar trials

Other recruiting trials for the same condition, with the eligibility rules written in plain language.

Browse similar trials
Talk to a specialist

Find a top oncologist who can tell you whether a trial is a sensible option for you.

Find a doctor
Cancer hospitals

The cancer centers running studies like this one, and what each is known for.

Browse hospitals